The results of the NN103 Beat MG have been posted online at the American Academy of Neurology. External Source: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG StudyRelated Project: NN103 Beat MG